Petrice M Cogswell1, L Taylor Davis1, Megan K Strother2, Carlos C Faraco1, Lori C Jordan3, Blaise deB Frederick4, Jeroen Hendrikse5, and Manus J Donahue1
1Radiology, Vanderbilt University, Nashville, TN, United States, 2DXP Imaging, Louisville, KY, United States, 3Neurology, Vanderbilt University, Nashville, TN, United States, 4McLean Hospital, Boston, MA, United States, 5University Medical Center Utrecht, Utrecht, Netherlands
Synopsis
No
study to date has assessed the relationship between intracranial vessel plaque
and wall thickening and its impact on tissue-level function. A novel
intracranial vessel wall imaging protocol and BOLD imaging were applied in
patients with intracranial stenosis secondary to atherosclerosis and moyamoya
disease (non-atherosclerotic stenosis). The time of maximum correlation of BOLD data
with the applied stimulus, the CVR time, calculated using a novel time
regression technique, is prolonged in vascular territories with a proximal
vessel wall lesion for both atherosclerosis and moyamoya patients. The maximum z-statistic, a qualitative metric
of CVR, is decreased in vascular territories with a proximal vessel wall lesion
in moyamoya patients only.Purpose
High spatial resolution intracranial vessel wall
imaging and blood oxygenation level-dependent (BOLD) measures of hypercapnia-induced
cerebrovascular reactivity (CVR) are being applied more frequently to evaluate structural
and functional changes in patients with intracranial stenosis at risk for
stroke. However, no study to date has assessed the relationship between intracranial
vessel plaque and wall thickening and its impact on tissue-level function. Specifically,
it is unclear whether altered CVR in regions of intracranial stenosis represent
delayed blood arrival time, reduced reactivity, or delayed reactivity time, all
of which may represent different indicators of disease severity and endothelial
function, and may require distinct treatments. The purpose of this work is (1) to
apply a novel intracranial vessel wall imaging protocol in a group of patients
with intracranial stenosis secondary to atherosclerosis and moyamoya disease (non-atherosclerotic
stenosis), and (2) to separately quantify reactivity time and reactivity
magnitude in flow territories perfused by vessels with vessel wall disease.
Methods
Experiment. All volunteers
(n=36) provided informed, written consent. Inclusion criteria were stroke or
TIA within 30 days, intracranial stenosis > 50%, and extracranial stenosis
< 70%. Vessel wall imaging was performed on a 3T whole-body system (Philips)
in the coronal plane using a custom 3D turbo spin echo (TSE) proton density-weighted
sequence with long TSE readout (blood water nulling) and anti-driven
equilibrium module (CSF water nulling). Imaging parameters: FOV=200mm x 166mm,
spatial resolution=0.6 x 0.5 x 0.5 mm3, TR/TE=1500/38.5ms, TSE
factor=56. BOLD imaging (TR/TE 2000/35 ms) was performed using a three-minute hypercapnic
stimulus (5% CO2) interleaved with three-minutes normocapnic room
air and repeated twice. Analysis. The
time of maximum correlation of BOLD data with the applied stimulus, the CVR
time, was calculated using a novel time regression technique1 and
the maximum z-statistic was recorded as a qualitative metric of CVR. Means and
standard deviations of the CVR time and maximum CVR were calculated within each
of the ASPECTS2 territories (right and left A1, A2, M1-M6, P1, and
P2) as well as the total vascular territories including the right and left
anterior cerebral artery (ACA), middle cerebral artery (MCA), and posterior cerebral
artery territories (PCA). A board certified radiologist performed a blinded
review of the vessel wall imaging for lesion determination, defined as
concentric or eccentric vessel wall thickening or increased signal on proton
density imaging. The intracranial internal carotid arteries, A1, M1, and P1
segments were evaluated for each patient. The CVR time and maximum CVR values
were compared (two-tailed Student’s t-test) between patients with and without a
proximal vessel wall lesion for each vascular territory and for all territories
combined.
Results
36 patients were included in the study, 16 with
atherosclerosis and 20 with moyamoya disease. Representative patient examples
are shown in Figure 1. CVR time was significantly prolonged in flow territories
with vs. those without a proximal vessel wall lesion for both the
atherosclerosis and moyamoya patient groups (Table 1). Similar analysis for maximum
CVR showed a significant decrease in the moyamoya group but not the
atherosclerosis group. When each vascular territory was separately evaluated,
the average CVR time was prolonged and the maximum CVR decreased in territories
with a proximal vessel wall lesion compared to those without a proximal vessel
wall lesion for the moyamoya group (Figure 2).
The atherosclerosis group shows a similar trend, though the differences do
not meet criteria for statistical significance. The PCA territory was not
included in this analysis due to the small number of posterior circulation
vessel wall lesions.
Conclusion
Intracranial vessel wall imaging without
intravenous contrast can depict lesions in patients with intracranial stenosis,
and these lesions are shown to correlate with functional changes of
cerebrovascular reactivity. Vascular
territories with a proximal vessel wall lesion are shown to have a prolonged
CVR time in both patient groups, though the differences are more marked in the
moyamoya group than the atherosclerosis group possibly indicative of different
mechanisms of endothelial dysfunction in atherosclerotic vs.
non-atherosclerotic disease. The maximum
CVR was shown to be significantly decreased in the presence of a vessel wall
lesion in the moyamoya patients only, possibly indicating that it is CVR time,
rather than commonly-assumed overall reactivity, that is impaired in many
patients with atherosclerotic disease. Ongoing work focuses on assessing the effect
of luminal stenosis on CVR time and maximum CVR.
Acknowledgements
No acknowledgement found.References
1.
Donahue, M. J. et al. Time delay
processing of hypercapnic fMRI allows quantitative parameterization of
cerebrovascular reactivity and blood flow delays. J Cereb Blood Flow Metab. In print.
2.
Pexman, J. H. W. et al. Use of the Alberta Stroke Program Early CT Score
(ASPECTS) for Assessing CT Scans in Patients with Acute Stroke. Am. J.
Neuroradiol. 22, 1534–1542 (2001).